AAP
SMMT icon

Arax Advisory Partners’s Summit Therapeutics SMMT Stock Holding History

Arax Advisory Partners’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.98K Buy
105
+11
+12% +$178 ﹤0.01% 3107
2025
Q4 		$1.64K Sell
94
-12
-11% -$226 ﹤0.01% 3331
2025
Q3 		$2.19K Buy
+106
New +$2.57K ﹤0.01% 3097
2025
Q1 		– Sell
-797
Closed -$14.2K – 3013
2024
Q4 		$14.2K Sell
797
-222
-22% -$4.3K ﹤0.01% 1356
2024
Q3 		$22.3K Hold
1,019
– – ﹤0.01% 1039
2024
Q2 		$7.95K Buy
+1,019
New +$5.5K ﹤0.01% 1380

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return